Matt Schissler A quick comment to the last two questions: I understand where they come from. Investor frustration. Stock is down, so the "boo birds" come out. To them I ask: Do you truly believe that CBAI management wants to stock to be where it is? If you do, you need your e-trade account taken away. Outside of that, you must ...know that the management works tirelessly here. We know what we need to do. 1. get profitable, and 2. create an earth shaking event that affects our cap structure. Doing both of these get us out of being in the penny stock "do-loop." Rocket up, leak down. In order to graduate to a larger board, the above two items need to be accomplished. We know this. We work unabated on this. There is no silver bullet. We're confident it will happen and it is our focus. In the interim, the ups and downs are frustrating), but it does not deter us from accomplishing what we repeatedly have said, to be the world's largest, most significant stem cell storage company.
Matt Schissler Is it a goal of the company moving forward to attract institutional investment for even further expansion/aquisition opportunities?
ANS: Yes. this goes hand in hand with the previous question. We have institutional investment, as it is a generic term. What we seek is strategic investment. We believe now is the time... to stop being a penny stock, to attract strategic investors, and to make a bold move that no one would have even fathomed we could do. We made a bold move in late 2006, by buying CorCell. An industry insider said "you could have knocked me over with a feather..." when she heard the news. We were tiny. No one thought we could have pulled it off. We did. I've said all year we have a voracious appetite. I said all year about growth, acquisition, diversification. We've made those moves so far. But a strategic investment allows us to have another feather knock down moment again. That's the focus. Voracious appetite.See
Matt Schissler Is a potential uplisting to a reputable exchange written anywhere within CBAI's strategic growth strategy for success?
ANS: Great question Antonio. Disclaimer - since I have not revealed a specific strategy publicly, I need to keep this generic. 1. Yes. The CBAI management has no desire to stay on the BB forever. ... We're almost six years of fully reporting on the OTCBB. It has its advantages over larger exchanges, which has helped us accomplish what we have so far. But it's time to graduate from the OTCBB, provided we meet the larger requirements of a national exchange. The goal is to get to a national exchange, sooner rather than later. We need to meet national exchange requirements. There is a much larger strategy behind this, one I believe the shareholders will foam at the mouth for. Stay tuned. That is all I can say right now.See
How do you feel this will affect CBAI.? Wide open question.
ANS: it won't. ESC's ban is federal funding...that's it. private money has been behind it for years. So has foreign governments. Adult stem cells are shwoing even greater promise. ESC's are just a cheap alternative for domest...ic R&D companies, but it does not nor will it affect CBAI. Stem cell therapies will continue to thrive, overseas or with adult cells.
